Ticker · CUSIP 10919W405
Holders (tracked)
5
Combined shares
217,473
Combined value
$16.97M
Last close
$89.90
Quarter
2025Q4
Price · 1Y$89.90+56.79 (+171.52%)H $95.99 · L $23.27 · Avg Vol 116K
Position opened
Tracked holders · last 8 quarters
Flat over the last 8 quarters.
Price is +15.2% vs the avg quarter-end implied price across tracked holders.
SEC event timeline
12 events
- T. Rowe Price opened position2026-02-17+2,830 shares · 2025Q4Position
- D.E. Shaw & Co. opened position2026-02-17+3,917 shares · 2025Q4Position
- Wellington Management opened position2026-02-17+13,688 shares · 2025Q4Position
- Two Sigma Investments trimmed2026-02-17−8,110 shares · 2025Q4Position
- Izzy Englander (Millennium Mgmt) added2026-02-17+117,756 shares · 2025Q4Position
- Steve Cohen (Point72) exited2026-02-17−105,020 shares · 2025Q4Position
- Ken Griffin (Citadel Advisors) exited2026-02-17−6,476 shares · 2025Q4Position
- Renaissance Technologies exited2026-02-12−3,500 shares · 2025Q4Position
- Izzy Englander (Millennium Mgmt) trimmed2025-11-14−34,690 shares · 2025Q3Position
- Steve Cohen (Point72) trimmed2025-11-14−30,000 shares · 2025Q3Position
- Two Sigma Investments opened position2025-11-14+10,711 shares · 2025Q3Position
- Renaissance Technologies opened position2025-11-13+3,500 shares · 2025Q3Position
Insider activity
No insider transactions in the last 30 days.
Follow-the-investor returns
If you'd copied each holder of DRUG…
Cost basis inferred from each manager's quarter-over-quarter position changes. Sorted by % return on the position they're still holding.
| Investor | First in | Cost basis | Return | Position value today |
|---|---|---|---|---|
| Two Sigma Investments | 2025Q3 | $60.66 | +48.2% | $234K |
| Izzy Englander (Millennium Mgmt) | 2024Q4 | $61.48 | +46.2% | $17.5M |
| Wellington Management | 2025Q4 | $78.04 | +15.2% | $1.2M |
| D.E. Shaw & Co. | 2025Q4 | $78.04 | +15.2% | $352K |
| T. Rowe Price | 2025Q4 | $78.09 | +15.1% | $254K |
Who moved on this name in 2025Q4
Position changes reported for the latest quarter, grouped by direction.
New positions3
- Wellington Management+13,688$1.1M
- D.E. Shaw & Co.+3,917$306K
- T. Rowe Price+2,830$221
Added to1
- Izzy Englander (Millennium Mgmt)+117,756$9.2M
Trimmed1
- Two Sigma Investments−8,110$633K
Exited3
- Steve Cohen (Point72)−105,020$6.4M
- Ken Griffin (Citadel Advisors)−6,476$393K
- Renaissance Technologies−3,500$212K
Institutional ownership over time
Distinct super-investors holding this ticker · combined dollar value, by quarter.
| Quarter | Holders | Combined value |
|---|---|---|
| 2023Q3 | 1 | $2 |
| 2023Q4 | 2 | $17K |
| 2024Q1 | 2 | $21K |
| 2024Q2 | 1 | $1 |
| 2024Q4 | 2 | $6.3M |
| 2025Q1 | 3 | $12.1M |
| 2025Q2 | 2 | $6.4M |
| 2025Q3 | 5 | $12.3M |
| 2025Q4 | 5 | $17.0M |
Who owns DRUG
5 super-investors · 2025Q4
Tracked stake
217.5K
shares
Combined value
$17M
% of shares outstanding
—
shares-out unknown
Quarter action mix
New3Added1Trim1
| # | Manager | Shares | Value |
|---|---|---|---|
| 1 | Izzy Englander Millennium Mgmt | 194.4K | $15M |
| 2 | Wellington Management | 13.7K | $1M |
| 3 | D.E. Shaw & Co. | 3.9K | $306K |
| 4 | T. Rowe Price | 2.8K | $221K |
| 5 | Two Sigma Investments | 2.6K | $203K |
Recent moves
20 transactions
- +2,830 · 2025Q4
- −6,476 · 2025Q4
- +13,688 · 2025Q4
- −8,110 · 2025Q4
- +117,756 · 2025Q4
- −105,020 · 2025Q4
- +3,917 · 2025Q4
- −3,500 · 2025Q4
- +10,711 · 2025Q3
- −34,690 · 2025Q3
- −30,000 · 2025Q3
- +3,500 · 2025Q3
- −81,186 · 2025Q2
- −169 · 2025Q1
- +152,178 · 2025Q1
- +135,189 · 2024Q4
- +40,379 · 2024Q4
- −11,996 · 2024Q1
- +11,996 · 2023Q4
- NEWBlackRock+1 · 2023Q3
Embed this chart
Paste this iframe anywhere to embed the live DRUG chart.
<iframe src="https://openstocks.me/embed/stocks/DRUG" width="100%" height="480" frameborder="0" loading="lazy" title="DRUG chart by OpenStocks" style="border:0;border-radius:12px;background:transparent"></iframe>Explore related topics
- DRUG insider tradingEvery Form 4 filing by DRUG officers, directors, and 10%+ holders.
- DRUG analyst target pricesWall Street consensus target, analyst-by-analyst breakdown, and revision history.
- Most popular hedge-fund stocksSee where this ticker ranks against the broader smart-money consensus.
- All insider tradingCross-ticker view of where corporate insiders are buying on the open market.
- Congress stock tradesReal-time PTR disclosures filed under the STOCK Act.
- Smart-money signalsComposite signals where institutional, insider and Congress flows converge.